List of Proair Digihaler drug patents

Proair Digihaler is owned by Teva Branded Pharm.

Proair Digihaler contains Albuterol Sulfate.

Proair Digihaler has a total of 22 drug patents out of which 0 drug patents have expired.

Proair Digihaler was authorised for market use on 31 March, 2015.

Proair Digihaler is available in powder, metered;inhalation dosage forms.

The generics of Proair Digihaler are possible to be released after 22 February, 2041.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7540282 TEVA BRANDED PHARM Reservoir pressure system for medicament inhaler
May, 2023

(3 months from now)

US10765820 TEVA BRANDED PHARM Dry powder inhalation apparatus
May, 2025

(2 years from now)

US9463288 TEVA BRANDED PHARM Dry powder inhalation apparatus
May, 2025

(2 years from now)

US8651103 TEVA BRANDED PHARM Dry powder inhalation apparatus
Mar, 2028

(5 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(8 years from now)

US9731087 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(8 years from now)

US10124131 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US9216260 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jun, 2031

(8 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(8 years from now)

US8978966 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jan, 2032

(8 years from now)

US9782550 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(12 years from now)

US9782551 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(12 years from now)

US10918816 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Dec, 2035

(12 years from now)

US10569034 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2036

(13 years from now)

US11351317 TEVA BRANDED PHARM Drug delivery device with electronics
Feb, 2038

(15 years from now)

US11357935 TEVA BRANDED PHARM Drug delivery device with electronics
Sep, 2038

(15 years from now)

US11000653 TEVA BRANDED PHARM Inhaler
Dec, 2038

(15 years from now)

US11344685 TEVA BRANDED PHARM Drug delivery device with electronics
Sep, 2039

(16 years from now)

US11439777 TEVA BRANDED PHARM Drug delivery device with electronics
May, 2040

(17 years from now)

US11464923 TEVA BRANDED PHARM Inhaler system
Jun, 2040

(17 years from now)

US11173259 TEVA BRANDED PHARM Drug delivery device with electronics and power management
Jul, 2040

(17 years from now)

US11266796 TEVA BRANDED PHARM Inhalation device with integrated electronics
Feb, 2041

(18 years from now)

Drugs and Companies using ALBUTEROL SULFATE ingredient

Market Authorisation Date: 31 March, 2015

Treatment: NA

Dosage: POWDER, METERED;INHALATION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in